Back to search

Article

Pentagalloylglucose ameliorates acute respiratory distress syndrome by targeting PFKFB2-mediated neutrophil glycolysis and inflammation

2026-08-11

Abstract excerpt

<title>Abstract</title> <p>Background Acute respiratory distress syndrome (ARDS) is a life-threatening clinical syndrome characterized by acute hypoxemic respiratory failure, with mortality rates ranging from 30% to 50% in critically ill patients. Despite decades of research, effective targeted therapies remain limited. Metabolic reprogramming and excessive neutrophil-mediated inflammation are central pathologic...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
193225ff-ff1f-5fa5-a8dc-0c213cbe1673
DOI
10.21203/rs.3.rs-10380478/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Pentagalloylglucose ameliorates acute respiratory distress syndrome by targeting PFKFB2-mediated neutrophil glycolysis and inflammationDOI 10.21203/rs.3.rs-10380478/v1
Select a neighboring publication to make it the new centre.